377 related articles for article (PubMed ID: 24407360)
1. Impact of complementary and alternative medicine on the quality of life in inflammatory bowel disease: results from a French national survey.
Abitbol V; Lahmek P; Buisson A; Olympie A; Poupardin C; Chaussade S; Lesgourgues B; Nahon S
Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):288-94. PubMed ID: 24407360
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease.
Weizman AV; Ahn E; Thanabalan R; Leung W; Croitoru K; Silverberg MS; Steinhart AH; Nguyen GC
Aliment Pharmacol Ther; 2012 Feb; 35(3):342-9. PubMed ID: 22176478
[TBL] [Abstract][Full Text] [Related]
3. The Manitoba Inflammatory Bowel Disease Cohort Study: a prospective longitudinal evaluation of the use of complementary and alternative medicine services and products.
Rawsthorne P; Clara I; Graff LA; Bernstein KI; Carr R; Walker JR; Ediger J; Rogala L; Miller N; Bernstein CN
Gut; 2012 Apr; 61(4):521-7. PubMed ID: 21836028
[TBL] [Abstract][Full Text] [Related]
4. Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey.
Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
Am J Gastroenterol; 2003 Jul; 98(7):1563-8. PubMed ID: 12873578
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors of complementary and alternative medicine use for patients with inflammatory bowel disease in Korea.
Park DI; Cha JM; Kim HS; Park HJ; Shin JE; Hong SN; Hong SS; Kim WJ
Complement Ther Med; 2014 Feb; 22(1):87-93. PubMed ID: 24559822
[TBL] [Abstract][Full Text] [Related]
6. [Treatment adherence and use of complementary and alternative medicine in patients with inflammatory bowel disease].
Lakatos L; Czeglédi Z; Dávid G; Kispál Z; Kiss LS; Palatka K; Kristóf T; Molnár T; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovács A; Rácz I; Lakatos PL
Orv Hetil; 2010 Feb; 151(7):250-8. PubMed ID: 20133244
[TBL] [Abstract][Full Text] [Related]
7. Patterns of complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease: perceived stress is a potential indicator for CAM use.
Langhorst J; Anthonisen IB; Steder-Neukamm U; Luedtke R; Spahn G; Michalsen A; Dobos GJ
Complement Ther Med; 2007 Mar; 15(1):30-7. PubMed ID: 17352969
[TBL] [Abstract][Full Text] [Related]
8. Complementary medicine use in children and young adults with inflammatory bowel disease.
Heuschkel R; Afzal N; Wuerth A; Zurakowski D; Leichtner A; Kemper K; Tolia V; Bousvaros A
Am J Gastroenterol; 2002 Feb; 97(2):382-8. PubMed ID: 11866277
[TBL] [Abstract][Full Text] [Related]
9. Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease.
Lakatos PL; Czegledi Z; David G; Kispal Z; Kiss LS; Palatka K; Kristof T; Nagy F; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovacs A; Racz I; Lakatos L
J Crohns Colitis; 2010 Sep; 4(3):283-90. PubMed ID: 21122517
[TBL] [Abstract][Full Text] [Related]
10. Use of Complementary and Alternative Medicine for Inflammatory Bowel Disease Is Associated with Worse Adherence to Conventional Therapy: The COMPLIANT Study.
Nguyen GC; Croitoru K; Silverberg MS; Steinhart AH; Weizman AV
Inflamm Bowel Dis; 2016 Jun; 22(6):1412-7. PubMed ID: 27120570
[TBL] [Abstract][Full Text] [Related]
11. Complementary and alternative medicine use, spending, and quality of life in early stage breast cancer.
Wyatt G; Sikorskii A; Wills CE; Su H
Nurs Res; 2010; 59(1):58-66. PubMed ID: 20010046
[TBL] [Abstract][Full Text] [Related]
12. Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study.
Oxelmark L; Lindberg A; Löfberg R; Sternby B; Eriksson A; Almer S; Befrits R; Fossum B; Karlén P; Broström O; Tysk C;
Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1320-8. PubMed ID: 27472271
[TBL] [Abstract][Full Text] [Related]
13. Health-related self-perceptions over time and provider-based Complementary and Alternative Medicine (CAM) use in people with inflammatory bowel disease or arthritis.
Sirois FM
Complement Ther Med; 2014 Aug; 22(4):701-9. PubMed ID: 25146075
[TBL] [Abstract][Full Text] [Related]
14. E-health: Web-guided therapy and disease self-management in ulcerative colitis. Impact on disease outcome, quality of life and compliance.
Elkjaer M
Dan Med J; 2012 Jul; 59(7):B4478. PubMed ID: 22759851
[TBL] [Abstract][Full Text] [Related]
15. Cannabis use amongst patients with inflammatory bowel disease.
Lal S; Prasad N; Ryan M; Tangri S; Silverberg MS; Gordon A; Steinhart H
Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):891-6. PubMed ID: 21795981
[TBL] [Abstract][Full Text] [Related]
16. Complementary and alternative medicine in patients with inflammatory bowel disease: A survey performed in a tertiary center in Chile.
Fernández A; Simian D; Quera R; Flores L; Ibáñez P; Lubascher J; Figueroa C; Kronberg U; Pizarro G; Fluxá D
Complement Ther Med; 2018 Oct; 40():77-82. PubMed ID: 30219473
[TBL] [Abstract][Full Text] [Related]
17. Use of alternative and complementary therapies in children with cancer.
Martel D; Bussières JF; Théorêt Y; Lebel D; Kish S; Moghrabi A; Laurier C
Pediatr Blood Cancer; 2005 Jun; 44(7):660-8. PubMed ID: 15714446
[TBL] [Abstract][Full Text] [Related]
18. Use of complementary and alternative medicines by children and adolescents with inflammatory bowel disease.
Day AS; Whitten KE; Bohane TD
J Paediatr Child Health; 2004 Dec; 40(12):681-4. PubMed ID: 15569284
[TBL] [Abstract][Full Text] [Related]
19. Impact of inflammatory bowel disease on Japanese patients' quality of life: results of a patient questionnaire survey.
Ueno F; Nakayama Y; Hagiwara E; Kurimoto S; Hibi T
J Gastroenterol; 2017 May; 52(5):555-567. PubMed ID: 27470433
[TBL] [Abstract][Full Text] [Related]
20. Doctor communication quality and Friends' attitudes influence complementary medicine use in inflammatory bowel disease.
Mountifield R; Andrews JM; Mikocka-Walus A; Bampton P
World J Gastroenterol; 2015 Mar; 21(12):3663-70. PubMed ID: 25834335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
